-transparent.png){kind=logo}
This study demonstrated the decrease of bone mineral density (BMD) in the type II collagen (CII)-induced arthritis (CIA) model in rats and the relationship between BMD and paw edema and the effect of dexamethasone-21-phosphate (DEX). The paw swelling occurred on Day 10 and reached its peak on Day 18 after CII injection. BMD in the CII-injected group is lower than that in the control group. BMD in the proximal and distal regions of the femur largely decreased in comparison with that of the middle region. The oral administration of DEX (0.1 mg/kg) inhibited the swelling and decrease of BMD in all three regions of the femur.
Related Publications
T Takagi, and
P W Tsao, and
R Totsuka, and
T Suzuki, and
T Murata, and
I Takata
January 2009,
Aviakosmicheskaia i ekologicheskaia meditsina = Aerospace and environmental medicine,
T Takagi, and
P W Tsao, and
R Totsuka, and
T Suzuki, and
T Murata, and
I Takata
February 2011,
Calcified tissue international,
T Takagi, and
P W Tsao, and
R Totsuka, and
T Suzuki, and
T Murata, and
I Takata
January 2000,
The Journal of veterinary medical science,
T Takagi, and
P W Tsao, and
R Totsuka, and
T Suzuki, and
T Murata, and
I Takata
June 2021,
Inflammopharmacology,
T Takagi, and
P W Tsao, and
R Totsuka, and
T Suzuki, and
T Murata, and
I Takata
December 1996,
Bone,
T Takagi, and
P W Tsao, and
R Totsuka, and
T Suzuki, and
T Murata, and
I Takata
November 2005,
Journal of autoimmunity,
T Takagi, and
P W Tsao, and
R Totsuka, and
T Suzuki, and
T Murata, and
I Takata
January 1985,
Annals of the New York Academy of Sciences,
T Takagi, and
P W Tsao, and
R Totsuka, and
T Suzuki, and
T Murata, and
I Takata
October 2015,
Pharmacology research & perspectives,
T Takagi, and
P W Tsao, and
R Totsuka, and
T Suzuki, and
T Murata, and
I Takata
January 1980,
The Journal of rheumatology,
T Takagi, and
P W Tsao, and
R Totsuka, and
T Suzuki, and
T Murata, and
I Takata
June 2013,
International immunopharmacology,
